Freestone Grove Partners’s Option Care Health OPCH Stock Holding History

Freestone Grove Partners’s Portfolio OPCH Stock Details OPCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.01M	Sell	334,125 -905,448	-73%	-$21.1M	0.05%	323
2026 Q1	$33.4M	Buy	1,239,573 +323,675	+35%	+$10.5M	0.24%	146
2025 Q4	$29.2M	Buy	+915,898	New	+$26.9M	0.21%	160
2025 Q3	–	Sell	-1,156,164	Closed	-$37.6M	–	854
2025 Q2	$37.6M	Buy	1,156,164 +437,834	+61%	+$14.1M	0.28%	133
2025 Q1	$25.1M	Sell	718,330 -35,421	-5%	-$1.11M	0.26%	145
2024 Q4	$17.5M	Buy	+753,751	New	+$19M	0.21%	151

Other funds holding OPCH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Freestone Grove Partners's OPCH Position: Q2 2026 in Review

Freestone Grove Partners reduced its Option Care Health (OPCH) stake by 73% in Q2 2026, selling an estimated $21.1M and leaving 334,125 shares worth $7.01M. The position accounts for 0.05% of the portfolio, ranked #323.

Freestone Grove Partners first reported a position in OPCH in Q4 2024 and has held it in 6 quarters since. The position peaked at $37.6M in Q2 2025. 372 funds tracked by Wall St. Rank hold OPCH as of Q2 2026.

Freestone Grove Partners held 334,125 shares of Option Care Health worth $7.01M as of Q2 2026.
Freestone Grove Partners sold 905,448 Option Care Health shares in Q2 2026, an estimated $21.1M.
Option Care Health made up 0.05% of Freestone Grove Partners's portfolio in Q2 2026, its #323 holding.
Freestone Grove Partners first reported a position in Option Care Health in Q4 2024 and has held it in 6 quarters since.
Freestone Grove Partners's Option Care Health position peaked at $37.6M in Q2 2025.
372 funds tracked by Wall St. Rank held Option Care Health as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.